Abstract
Antibodies
The antibodies used for the Western blotting were as follows: mouse monoclonal anti-α1-ACT antibody (1:1000; Abcam, Cambridge, United Kingdom)mouse monoclonal anti-PTEN antibody (1:1000; Abcam, Cambridge, United Kingdom), rabbit monoclonal anti-MMP2 antibody (1:1000; Abcam, Cambridge, United Kingdom), rabbit monoclonal anti-MMP9 antibody(1:1000; Abcam, Cambridge, United Kingdom), rabbitpolyclonal anti-PI3Kantibody (1:1000; Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-phospho-PI3K p85 antibody(1:1000; Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-AKT antibody (1:1000; Abcam, Cambridge, United Kingdom), rabbit polyclonal antiphospho-AKT473 antibody(1:1000; Abcam, Cambridge, United Kingdom),rabbit polyclonal anti-mTOR antibody (1:1000; abcam, Cambridge, United Kingdom), rabbit polyclonal anti-phospho-mTOR antibody (1:1000; Abcam,Cambridge, United Kingdom),rabbit monoclonal anti-GAPDH antibody (1:1000;Cell SignallingTechnology, USA). The secondary antibody incubation was performed using horseradish peroxidase-conjugated IgG (Cell SignallingTechnology, USA) at a dilution of1:2000. Rabbit polyclonal anti-P21(1:1000; Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-PARP(1:1000; abcam, Cambridge, the), rabbit polyclonal anti-cleaved-PARP (1:1000; Abcam,Cam bridge, the United Kingdom), Table 1 . Correlation of α1-ACT and Ki-67 expression with clinicopathological factors in HCC specimens. Statistical analyses were performed by the Pearsonχ2test, *P< 0.05 was considered significant rabbit polyclonal anti-BAX(1:1000; Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-BAD (1:1000; Abcam,Cambridge,United Kingdom), rabbit polyclonal anti-Bcl2(1:1000; Abcam,Cambridge, United Kingdom). The antibodies used for immunohistochemistry were as follows: mouse monoclonal anti-α1-ACT antibody (1:100; Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-phospho-PI3K antibody(1:200;Abcam, Cambridge, United KingdoSm), rabbit polyclonal anti-BAX (1:100;Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-BAD(1:100;Abcam, Cambridge, United Kingdom), rabbit polyclonal anti-cleaved-PARP (1:100;Abcam, Cambridge, United Kingdom), and rabbit polyclonal anti-Ki67(1:100; Abcam, Cambridge, United Kingdom).
Immunohistochemistry
The fresh tumour tissues were fixed in 4% paraformaldehyde and embedded in paraffin. The 5-μm-thick sections were dewaxed twice in xylene for 10 min and rehydrated in ethanol. The sections were washed with PBS (phosphate-buffered saline,pH 7.4) 3 times for 3 min. Then, the slides were boiled in 10 mM/L citrate buffer (pH 6.0) in an autoclave for 3 min for antigen retrieval. After slowly cooling, the sections were blocked by immersion in 3% methanolic peroxide for 15 min and incubated with the following primary antibodies: antibodies against α1-ACT, p-PI3K, BAX,BAD,Ki67, cleaved PARP overnight at 4°C, followed by horseradish peroxidase(HRP)-conjugated secondary antibodies. After washing with water, the slides were counterstained with haematoxylin, dehydrated, and mounted in resin mount.
All the slides were examined by 3 independent pathologists in a blinded manner without knowing any of the clinical and pathological information about the patients. For evaluating the expression levels of α1-ACT, p-PI3K, p-AKT, p-mTOR, Ki-67, p21, BAX, BAD and cleaved PARP, at least six high-power fields for each specimen were selected, and the cytoplasm or nuclear staining were examined under a high-power lens. In addition, more than 500 cells were inspected to determine the mean percentage of the signal-positive cells. To quantify the α1-ACTexpression, the H-score (histochemistry score) was calculated by the percentage of stained cells×staining intensity. The patients were divided into the two following groups: a high expression group (>medium value of all HCC H-score) and a lower expression group (≤medium value of all HCC H-score) according to the α1-ACT expression.
Cell culture
Five hepatocellular carcinoma cell lines (Hep3B, HepG2, MHCC-97H, SMMC-7721 and Huh7) LO2 and 293T cells were purchased from the Shanghai Cell Bank of the Chinese Scientific Academy. These cells were cultured in DMEM high glucose culture medium(Gibco Company, USA) supplemented with 10% foetal bovine serum (Gibco Company, USA) and 1% penicillin/streptomycin (Gibco Company, USA). The cells were cultured in cell culture dishes (Thermo, USA) under a humidified atmosphere containing 5% CO2at 37°C.
Plasmid construction and transfection
The pLV-GFP, 8.91 and VSVG plasmids that were used for the packaging of lentivirus are preserved in our laboratory. The G248-sh1-α1-ACT-GFPinterference plasmid and G248-sh2-α1-ACT-GFP plasmid were synthesized and provided by the JIKAI company(Shanghai, China). The pLV-α1-ACT-GFP plasmid was synthesized and provided by GENEWIZ Company of gene technology (Shanghai, China).The lentiviral packaging systems for the three plasmids consisted of a mixed DNA solution (20 µg pLV-GFP,G248-GFP, G248-sh1-α1-ACT-GFP, G248-sh2-α1-ACT-GFP and pLV-α1-ACT-GFP, 6μg pLR/VSV-G, 15μg pCMVΔ8.91) that was mixed well, and then sterile water was added to achieve the 500μl final volume. Then, 0.5 ml 2× HBS phosphate buffered saline solution and 50μl CaCl 2 (2.5 mM / L) were added to the DNA solution and gently mixed at room temperature for 20-25 min. The DNA mixture was then diluted with 5 ml fresh DMEM containing 10% FBS and 1% penicillin/streptomycin and was used to transfer the 293T cells. After 6-8 h, the medium containing the DNA mixture was discarded and 10 ml fresh DMEM was added to each culture dish. After 24 h, the transfection efficiency was evaluated using fluorescence microscope. The supernatant of the 293T cells was collected 48h after the transfection. The cell supernatant was centrifuged at 1500 rpm for 5 min at 4°C and then passed through a 0.45-μm filter. At the time of the transfection,5 ml viral supernatant and 50μL (1μg/μL) polybrene were added to the 97H or Huh7 cells in 10-cm cell culture plates. After 5 h, 5 ml fresh DMEM containing 10% FBS was added to every plate. After 24 h, the medium was changed, and48 h later,the GFP expressed by cells was observed under a fluorescence microscope for evaluating the transfection efficiency.
RNA extraction and Quantitative Real-time PCR
Total RNA was extracted from the HCC tissues, paracancerous tissues and cell lines by using TRNzol-A + Reagent according to the manufacturer's instructions (Tiangen Biotech Co., Beijing, China). The RNA from all the samples was reversed transcribed using a PrimeScript RT Master Mix kit (Takara, Tokyo, Japan). The mRNA levels ofα1-ACT were determined by quantitative real-time PCR (qRT-PCR) and calculated using the 2 −ΔΔCT method, with the CT values normalized using GAPDH as an internal control. The primers are as follows: α1-ACT, sense 5'-GCTCATCAACGACTACGTGAA-3' and anti-sense 5'-CACCATTACCCACTTTTTCTTGC-3';GAPDH,sense 5'-GGAGCGAG ATCCCTCCAAAAT-3' and anti-sense 5'-GGCTGTTGTCATACTTCTCATGG-3'. Real-time RT-PCR was performed using a SYBR Green PCR Master Mix (Takara, Tokyo, Japan)in an ABI Prism 7900HT instrument(Applied Biosystems, CA, USA)according to the manufacturer's instructions.
Cell proliferation analysis
To study the role of α1-ACT in cell proliferation, we used G248-sh1-α1-ACT-GFP and G248-sh2-α1-ACT-GFP to interfere with the expression of α1-ACT in the 97H cells, and we used the pLV-α1-ACT-GFP plasmid to overexpress α1-ACTin the Huh7 cells. Cell proliferation was analysed using a Cell Counting Kit-8 assay (CCK-8, Dojindo, Japan).
The Cell Counting Kit-8 assay was performed according to the manufacturer's instructions. Briefly, the cells were plated into 96-well plates at a density of 2*10
Analysis of apoptosis in cells
The annexin V-PE/7-AAD apoptotic analysis of flow cytometry was used to analyse cell apoptosis. An Annexin V-FITC Apoptosis Detection Kit (BD Biopharmingen, NJ, USA) was used for flowcytometric analysis. The G248-GFP-, G248-sh1-α1-ACT-GFP-, G248-sh2-α1-ACT-GFP-transfected 97H cells and the pLV-α1-ACT-GFP-, PLV-GFP-transfected Huh7 cells in the logarithmic phase were subjected to the annex in V-PE/7-AAD apoptotic analysis. For this analysis, approximately 3×10 4 cells in the logarithmic phase were digested by pancreatic enzymes containing no EDTA,washed in PBS and centrifuged at 1500 rpm for 5 min at 4°C twice. The cells were then stained with annexin V-FITC for 15 min in the dark. All the experiments were analysed using a BD Biosciences FACSCalibur flow cytometer (BD Biosciences, NJ, USA). The tests were repeated three times, and triplicate wells were used for each condition.
Cell cycle analysis
The cell cycle analysis was performed using a Cell Cycle Staining Kit (Multisciences, China) following the manufacturer's instructions. Briefly, approximately 6×10 4 cells in the logarithmic phase were digested with pancreatic enzymes, washed in PBS and centrifuged at 2000 rpm for 5 min at 4°C twice. Then, the cells were fixed in 75% methanol for 4 h at −20°C, centrifuged at 1000 g for 5 min and then resuspended in 2 ml PBS for 15min.After that, the cells were centrifuged at 2000 rpm for 5min and washed with PBS three times. Subsequently, the cells were stained with 1 ml DNA staining solution (Multisciences, China) for 30 min. Finally, a BD FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) coupled with the Cell Quest acquisition and analysis programs was used to analyse the cell cycle distribution.
Cell migration and invasion assay
We used a wound healing assay to evaluate the migration ability of the cells. For a wound healing assay, the HCC cells were seeded into six-well plates and allowed to grow to 80-90% confluence. A 200-μL sterile plastic tip was used to create a wound line across the surface of plates, and the cellular debris was removed by washing the plates with phosphate-buffered saline. The cells were cultured in DMEM in a humidified incubator under5% CO2 at 37°C for 72 h, and then images were taken with a phase-contrast microscope at 0 h and 72 h.
For the Transwell invasion assay, 2×10 
Protein extraction and Western blotting
Whole cells were washed in PBS and lysed in RIPA lysis buffer(strong) supplemented with PMSF and a protease inhibitor cocktail (Nanjing KaijiBiology Development Co., Ltd., Nanjing, China). The total protein was quantified using a BCA Protein Assay Kit (Beyotime, Jiangsu, China).The total cell lysate was separated by SDS-PAGE and transferred to polyvinylidenedifluoride membranes (0.45 µm, Millipore, Bedford, MA). The blotted membranes were blocked with Tris-bufferedsaline containing 0.05% Tween 20 (TBST)and 5% fat-free dry milk for 2 h at room temperature and incubated overnight with primary antibodies in TBST with 1% bovine serum albumin. After three 10-min washes with TBST, the membranes were further incubated for 2 h at room temperature with corresponding the horseradish peroxidase-conjugated secondary antibodies at the appropriate dilution. The immunoreactive protein bands were visualized by an ECL kit (Thermo, USA).
Co-immunoprecipitation(CoIP) assay
A RIPA lysis buffer(moderate) supplemented with PMSF and protease inhibitorcocktail (Nanjing Kaiji Biology Development Co., Ltd., Nanjing China) was used to lyse the cells after washing in PBS and to perform the immunoprecipitation. We used a Co-immunoprecipitation Kit(Thermo Fisher Scientific,Waltham,USA), rabbit monoclonal anti-α1-ACT antibody (1:1000; Abcam, Cambridge, United Kingdom), mouse monoclonal anti-PTEN antibody (1:1000; Abcam, Cambridge, United Kingdom), mouse monoclonal anti-PI3K antibody (1:1000;Abcam, Cambridge, United Kingdom)for the Co-IP, and all the experimental steps were conducted according to the manufacturer's instructions.
Xenograft tumourmouse model
All mouse experiments were performed in accordance with the approved guidelines from the IACUC of Nanjing Medical University. The methods were carried out in accordance with the approved guidelines. Male BALB/c nude mice (6 weeks of age) were subcutaneously injected with the G248-sh1-α1-ACT-GFP-and G248-GFP-transfected 97H cells and the pLV-α1-ACT-GFP-and pLV-GFP-transfected Huh7 cells (5×10 6 /0.1ml PBS) in separate groups (n=6 per group). The tumour volumes were monitored every 2 days. The tumourbearing mice were sacrificed 40 days after inoculation, and the tumours were removed.
Statistical analysis
All results are presented as the mean ± S.D. Student's t-tests were used to analyse significant differences between the samples. All the histograms were evaluated with GraphPad Prism software, version 4.0 (GraphPad, SanDiego California, USA). The statistical analyses were performed using Stata. 11.0. P<0.05 indicated statistically significant differences.
Results

Reduced expression ofα1-ACT in the HCC tissue and HCC cells
The mRNA expression levels of α1-ACT in 96 paired HCC and adjacent non-tumour tissues were examined by qRT-PCR and normalized to GAPDH. The results showed that α1-ACT mRNA levels were significantly decreased in the HCC tissues compared with the adjacent non-tumour tissues (p<0.001, Fig. 1a ). In addition, the protein levels of α1-ACT were measured by Westernblotting, and we found notably lower levels in the tumour tissues (Fig.  1b) .By immunohistochemistry, we found that the cancerous tissues had significantly lower expression levels ofα1-ACT than the adjacent non-cancerous liver tissues (Fig.1c) .Moreover, the α1-ACT expression levels were significantly downregulated in all the HCC cell lines compared with thosein the normal foetal hepatocyte LO2 cells (p<0.05, Fig. 1d ). These 
Correlation between α1-ACT expression and the clinicopathological variables in the patients with HCC
To explore the pathophysiological relationship between α1-ACT expression and the tumour characteristics, the clinicopathological data are summarized in Table 1 . The results showed that the expression level of α1-ACT was significantly correlated with the level of AFP (P=0.019), the AJCC stage (P=0.02), tumour size (P=0.011) and tumour invasion (P= 0.016), while the expression level of α1-ACT was not correlated with other factors, such as gender and age. Moreover, we also examined the correlation between the expression level of Ki-67 and the clinicopathological characteristics of the patients. We found that there was a significant correlation between the expression level of Ki-67 and the expression level of AFP (P=0.005) and the AJCC stage (P=0.009). However, the expression of Ki-67 was not correlated with other factors. Spearman's correlation coefficient was also used to analyse the relationship between the expression levels of α1-ACT and Ki-67 in the examined HCC tissues and indicated that there was a remarkable negative correlation between the expression levels of α1-ACT and Ki-67 (Fig. 2a) . These results suggested that the down-regulated expression level of α1-ACT may contribute to the progression of HCC.
Prognostic significance of the α1-ACT expression levels
To explore the correlation between the expression level of α1-ACT and patient survival, Kaplan-Meier analysis was performed on the data from a total of 96 patients with follow-up 
data. The survival curves revealed that the patients with HCC and low α1-ACT expression levels had poorer overall survival than those with highα1-ACT expression levels (Fig. 2b) . However, elevated Ki-67 expression levels predicted significantly shorter overall patient survival (Fig. 2c) . Moreover, we evaluated the association between the survival status of the patients and the clinicopathological parameters using univariate analysis and found The Kaplan-Meier analysis high H-score of the levels of α1-ACT (B) and Ki-67 (C) were positively and negatively correlated with patient survival rates, respectively.
that there was a significant correlation between the survival status of the patients and the clinicopathological factors, such as the level of AFP (P<0.001), the AJCC stage (P<0.001), the expression level of Ki-67 (P=0.002), and the expression level ofα1-ACT (P<0.001) ( Table  2 ). Multivariate analysis showed that the tumour size (P=0.010), the AJCC stage (P<0.001), and the expression level of α1-ACT (P=0.020) were independent prognostic factors for the patients with HCC (Table 3 ). These data demonstrated that α1-ACT maybe a valuable prognostic indicator for the prediction of patient survival.
α1-ACT regulated cell proliferation
To understand the effect of α1-ACT on cell proliferation,the α1-ACT knockdown and overexpressed HCC cell lines were established as shown in Fig. 3 a and b . A Cell Counting Kit-8 (CCK-8) assay and a colony formation assay were performed. The CCK-8 assay showed that the proliferation of the HCC cells was significantly increased in the α1-ACT knockdown, stable 97H cells compared with the control cells (Fig. 3c) ,whereas the overexpression of α1-ACT reduced the proliferation of the Huh 7 cells (Fig. 3c) .
The overexpression of α1-ACT in the pLV-α1-ACT-GFP-transfected Huh7 cells effectively decreased the colony number compared to the control G248-GFP-transfected group, and this effect was reversed in the G248-sh1-α1-ACT-GFP-and G248-sh2-α1-ACT-GFP-transfected 97H cells compared with the control G248-GFP-transfected cells. (Fig. 3d) The above mentioned results indicated that α1-ACT can significantly regulate cell proliferation.
α1-ACTpromotedHCC cell apoptosis and G1 cell cycle arrest
No previous studies have focusedon whetherα1-ACT caninduce cell apoptosis. To answer this question, we used flow cytometry on theHCC cells toanalyze the role ofα1-ACT inapoptosis.
The G248-sh1-α1-ACT-GFP-, G248-sh2-α1-ACT-GFP-, G248-GFP-transfectedgroups of the 97H cells and the pLV-α1-ACT-GFP-, pLV-GFP-transfected groups of the Huh7 cells in the logarithmic phase were subjected to annexin V-PE/7-AAD apoptotic analysis. The flow cytometry results showed that apoptosis was significantly elevated in the cells transfected with pLV-α1-ACT-GFP (vs. the pLV-GFP groups). Meanwhile, the results showed that the G248-sh1-α1-ACT-GFP-and G248-sh2-α1-ACT-GFP-transfected groups exhibited suppression of cell apoptosis (vs. the G248-GFP groups) (Fig. 4a) .To further investigate the mechanisms underlying theα1-ACT-induced apoptosis in the 97H and Huh7 cells, we also examined the protein expression of molecules that maybe involved in the apoptotic pathway, such as Bcl2,cleaved PARP, Bax and Bad. As shown in Fig. 4c , the levels of activation of cleaved PARP,Bax,Bad increased, while the level of activation of Bcl2 decreased in the Huh7 cells transfected with pLV-α1-ACT-GFP compared with the cells transfected with pLV-GFP. Meanwhile, the levels of activation of cleaved PARP, Bax and Bad were decreased,but the Table 3 . Contribution of various prognostic factors to survival by Cox regression analysis on 96 HCC specimens. Statistical analyses were performed using log-rank test *P< 0.05 was considered statistically significant level of activation of Bcl2 was increased in the 97H cells transfected with G248-sh1-α1-ACT-GFP and G248-sh2-α1-ACT-GFPcompared with the cells transfected with G248-GFP.These results indicated that the overexpression ofα1-ACT could promote HCC cell apoptosis by inhibiting the cleaved PARP and Bcl2 apoptotic pathway.
The cell cycle distribution analysis revealed that transfection of the Huh7 cells with pLV-α1-ACT-GFP induced the cell cycle arrestin the G0/G1 phase (vs. pLV-GFP group). A higher proportion of the cells was observed in the G0/G1phases, and a significantly lower proportion of the cells was found in both the S and G2/M phases (Fig.4b) . Conversely, the cell cycle distribution analysis in the 97H cells transfected with G248-sh1-α1-ACT-GFP and G248-sh2-α1-ACT-GFP showed an inverse result (vs. the G248-GFP group) (Fig. 4b) . Our mechanistic investigations demonstrated that the overexpression of α1-ACT promoted the protein level of p21, which can induce the cell cycle arrest in the G0/G1 phase (Fig. 4d) .
α1-ACTcaninhibit the migration and invasion abilities of the HCC cells by regulating MMP2 and MMP9
The wound healing assays revealed decreased motility of the Huh7 cells transfected with pLV-α1-ACT-GFP(vs. the pLV-GFP group), while the 97H cells transfected with G248-sh1-α1-ACT-GFP and G248-sh2-α1-ACT-GFP exhibited increased motility (vs.G248-GFP group) (Fig. 5a ).We next tested the effect of overexpression of α1-ACT on the invasive behaviour of the Huh7 cells and tested the effect of knockdown ofα1-ACT on the invasive behaviour of the 97H cells by an in vitro invasion assay. The results revealed decreased invasion of the Huh7 cells transfected with pLV-α1-ACT-GFP(vs. the pLV-GFP groups);on the other hand, the results showed increased invasion of the HCC cells after knockdown of α1-ACT(vs. the G248-GFP groups) (Fig. 5b) . The mechanistic investigations demonstrated that overexpression 
α1-ACT directly bound to PTEN and did not interact with PI3K
To understand the relationship between α1-ACT and PTEN, we determined whether α1-ACT can bind to PTEN directly.We immunoprecipitated lysates of the pLV-α1-ACT-GFP-transfected Huh7 cells with an anti-PTEN antibody and found that PTEN co-immunoprecipitated with α1-ACT (Fig. 7a) . In addition, we also performed another co-immunoprecipitation to determine whether α1-ACT could directly bind to PI3K. . 7 . Lysates of the pLV-α1-ACT-GFPtransfected Huh7 cells were immunoprecipitated with an anti-PTEN antibody, and PTEN was co-immunoprecipitated with α1-ACT (Fig. 7a) . Immunoblotting of the anti-PI3K immunoprecipitates from the pLV-α1-ACT-GFP-transfected Huh7 cells showed that PI3K could not co-immunoprecipitate with α1-ACT. (Fig. 7b) . Immunoblotting of the anti-PI3K immunoprecipitates from the pLV-α1-ACT-GFP-transfected Huh7 cells revealed that PI3K did not co-immunoprecipitate with α1-ACT. (Fig. 7b) .
α1-ACT inhibited HCC tumourigenesis
To explore whether α1-ACT affected tumourigenesis in vivo,the pLV-α1-ACT-GFP-and pLV-GFP-transfected Huh7 cells and the G248-sh1-α1-ACT-GFP-and G248-GFP-transfected 97H cells were injected into male BALB/c nude mice. We found that the tumour xenograft volume in the pLV-α1-ACT-GFP group was smaller than that in the pLV-GFP group (Fig.  8a,P<0.01) , and the tumour weight was also lighter in the pLV-α1-ACT-GFP group (Fig. 8a,  P<0 .01). The tumour xenograft growth in the pLV-α1-ACT-GFP group was slower than that in the pLV-GFP group on the12 th day (Fig. 8b) .Meanwhile, the tumour volume and weight were greater in the tumour xenograft of the G248-sh1-α1-ACT-GFP group than in the G248-GFP group (Fig. 8a, P<0.05) . The tumour xenograft growth in the pLV-sh1-α1-ACT-GFP group was faster than that in the G248-GFP group on the 15 th day (Fig. 8b ).All these results suggested that overexpression of α1-ACT may suppress tumour growth in vivo.
We performed an immunohistochemistry assay to determine the expression of the cell proliferation, cell cycle and cell apoptosis marker proteins (Ki-67, p21, cleaved PARP, Bcl2, Bad and Bax) in the xenograft tumour tissues. As shown in Fig. 8c , α1-ACT inhibited HCC cell proliferation and induced cell apoptosis and cell cycle arrest. The activation of the PI3K/ AKT/mTOR signalling pathway was also abrogated by α1-ACT in vivo (Fig. 8d) . These data also support the notion that α1-ACT inhibited the PI3K/AKT/mTOR signalling pathway and HCC tumourigenesis in vivo.
Discussion
Despite the improvements in surveillance and clinical treatment strategies for HCC, the prognosis of HCC remains poor because of the high rates of recurrence and metastasis [25, 26] . Finding novel molecular targets relevant to the prognosis and development of HCC for clinical practitioner and basic scientists is a substantial challenge. Previously, Santamaria et al. found that α1-ACT localizes tothe nuclei of hepatic cells and inhibits proliferation through promotion of chromatin condensation. Overexpression of α1-ACT slows the growth of HCC xenograft tumours in nude mice [11] . In this study, we found that the majority of Chinese clinical HCC samples have low α1-ACT expression compared with the adjacent non-cancerous tissues. In addition, we found that the expression of α1-ACT was significantly correlated with the AJCC stage, serum level of AFP, the expression of Ki67, and prognosis. There was a remarkable positive correlation between the expression levels of α1-ACT and cleaved PARP in the 96 pairs of HCC tissues, which was determined using Spearman's correlation coefficient. Univariate and multivariate analyses also indicated that α1-ACT could be an independent prognostic indicator of patient survival.
Moreover, we found that interference withα1-ACT in the 97H cells led to accelerated cell growth, increased cell migration, enhanced cell invasion, decreased G0/G1 phase in the cell cycle and suppressed apoptosis, whereas overexpression of α1-ACT in the Huh7 cells induced the opposite effects. Further investigation indicated that α1-ACT induces cell cycle arrest in the G0/G1 phase by upregulating the expression of p21 and inhibiting the invasion of HCC cells by suppressing MMP2 and MMP9. These results were consistent with previous studies; p21, which belongs to the Cip/Kip family, negatively regulates the cell cycle progression through the inhibition of the CDK-cyclin complexes [27] [28] [29] [30] . MMP2 and MMP9 are important for degrading basement membrane components and have been demonstrated to facilitate tumour invasion and metastasis in many types of cancer cells [31] [32] [33] . Several recent studies have shown that the activation of the PI3K/AKT signalling pathway correlates with increased expression of MMP-2 and MMP-9 at protein level and promotes cancer cell invasion [34] [35] [36] [37] [38] [39] . Among these studies, some authors have noted that PTEN suppresses the PI3K/Akt pathway to inhibit the expression levels of the MMP2 and MMP9 proteins [35, 39] . In addition, Jiang et al. reported that CYP3A5 overexpression limited MMP2/9 function and suppressed HCC migration and invasion both in vitro and in vivo by inhibiting mTORC2/AKT signalling [38] . In all of the above mentioned studies, activation of the PI3K/AKT signalling pathway results in the elevation of MMP2/MMP9 via a currently unknown mechanism. We speculate that α1-ACT regulates the expression levels of MMP2 and MMP9 by activating intracellular PI3K-AKT-mTOR-dependentproteolytic enzyme signalling, and a more in-depth analysis of this mechanism will be addressed in a future study. In contrast with our study, Santamaria et al. have found that α1-ACT inhibits cell cycle progression and anchorage-independent proliferation of HCC cells by tightly binding to the chromatin to promote a condensed state [11] . In endometrial cancer, Yang et al. demonstrated that α1-ACT promoted endometrial cancer cell proliferation by regulating the G2/M checkpoint in the cell cycle and inhibited cell apoptosis. The authors further discovered that the pro-proliferative effect ofα1-ACT on endometrial cancer was likely due to the activation of MAPK/ERK1/2 and PI3K/AKT/mTOR signalling [40] . In our study, we found that α1-ACT inhibited hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR axis to regulate the apoptosis-related proteins. The PI3K/AKT/mTOR pathway serves as a proto-oncogenic pathway, which is critical for cancer progression, including cellular proliferation, growth, survival, and drug resistance [41] . Overactivation of the signalling pathway has been observed in a variety of tumours,including hepatocellular carcinoma, ovarian cancer, multiple myeloma, breast cancer, prostate cancer, and others [42] [43] [44] [45] .Our results demonstrated that α1-ACT may modulate HCC cell viability by inducing cell cycle arrest and promoting cell apoptosis through inhibiting the PI3K/AKT/ mTOR signalling pathway.
A previous study showed that suppression of the PI3K/AKT/mTOR pathway can induce cell apoptosis and mitochondrial damage by the Bcl2 pathway [46] . On the other hand, suppression of the PI3K/AKT/mTOR pathway can induce transcriptional activity of FOXO3a to down-regulate MnSOD, which leads to increased levels of ROS that induce activation of the p53/p21 pathway [47] .Meanwhile, activation of AKT can suppress the apoptosis-associated protein Bad to inhibit apoptosis and counteract the function of p21 to reduce the G0/G1 phase of the cell cycle and accelerate cycle progression [48, 49] . We investigated whether the cell cycle and apoptosis-associated proteins that are downstream of the PI3K/AKT/ mTOR pathway were regulated by α1-ACT. We found that the pro-apoptotic proteins, such as cleaved PARP, Bad and Bax and the cell cycle-associated protein p21, were increased, while the anti-apoptotic protein Bcl-2 decreased in the presence of α1-ACT.
PTEN acts as an inhibitor of the PI3K/Akt pathway and can inhibit tumour cell growth and invasion by directly suppressing the PI3k/AKT pathway [21] . On the other hand, there was a negative feedback relationship between p-PI3K and PTEN, which indicates that a decrease in p-PI3K can also cause an increase in PTEN [22] .In our study, we found that the increase in PTEN was accompanied by the overexpression of α1-ACT; therefore, we next conducted a more in-depth study to elucidate the mechanism underlying the regulation of PTEN expression byα1-ACT. We performed a co-immunoprecipitation experiment to determine whether the α1-ACT protein extracted from the Huh7 cells transfected with an α1-ACT expression vector could bind to the PTEN protein in the HCC cells. We also performed another co-immunoprecipitation experiment and found that there is no binding between the α1-ACT protein and the PI3K protein.
To date, no report has demonstrated that significant up-regulation of α1-ACT expression levels in the liver during the acute-phase response can lead to hepatocellular apoptosis. However, in our study, we found that overexpression of α1-ACT in the HCC cells can induce apoptosis. This differential response may be due to the differential proliferative status of the hepatocytes in the liver (quiescence), and α1-ACT may have stronger apoptotic effects on the HCC cells (active proliferation). In addition, many cytokines similar to interleukin-1(IL-1) and interleukin-6(IL-6)that are involved in the acute-phase response (APR)are intimately involved in hepatic regulation of the APR [50] . STAT3, which activates many types of cytokine-driven inflammatory genes, is significantly up-regulated as a transcription factor that interacts with the APR elements when IL-6 induces the acute-phase response in the liver during inflammation [51] .The transcription factor STAT-3 becomes activated via Janus kinases (JAKs), which results in the induction of STAT-3-related genes, such as c-myc, that promote cell proliferation [52] . This effect may counteract the apoptosis induced by the overexpression of α1-ACT in the liver during the acute-phase response.IL-6 binds to the IL-6 receptor (IL-6R) and leads to the activation of the tyrosine kinase JAK1, which induces the activation of several intracellular signalling pathways,including the MAPK and PI3K pathway. This may offset the inhibitory effect ofα1-ACT on the PI3K/AKT/mTOR signalling pathway [53] .
Our mouse xenograft models confirmed that α1-ACT inhibited the growth of the subcutaneously implanted tumours and promoted cell apoptosis by inhibiting the PI3K/ AKT/mTOR signalling pathway. These results were consistent with the results of vitro experiments.
For the first time, this study showed the decreased expression levels of α1-ACT in HCC tissues,which were correlated with the plasma levels of AFP, the AJCC stage, cleaved PARP and poor prognosis. In addition, the COX regression analysis demonstrated thatα1-ACT could be an independent prognostic factor for the survival of HCC patients. We also found that α1-ACT induces cellular apoptosis and cell cycle arrest. Finally, we demonstrated that overexpression of α1-ACT promoted cell apoptosis in the HCC cells via inhibiting the PI3K/ AKT/mTOR signalling pathway both in vitro and in vivo. Our findings indicated that α1-ACT may be a novel potential target for the development of diagnostic and therapeutic strategies for HCC. On the other hand, α1-ACT could also serve as a prognostic marker for HCC.
